Partner Content Partner Content How Will Spark’s Approval Impact the Gene Therapy Field? Gene Therapy for Rare Disorders Summit
Partner Content Partner Content 7th Annual HPAPI Summit - Boston 2018 Explore Unique Potent Compound Case Studies
Partner Content Partner Content Microbiome Drug Development Boston - Your Invite Pioneering The Microbiome Into Effective Medicines
Events Partner Content Microbiome Drug Development Boston 2018 Pioneering The Microbiome Into Effective Medicines
Debates & Insight Sponsored Standing on the cusp of something great: How real-world data... REAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care
Events Partner Content Personalized and Precision Medicine International Conference... Int. Conference on Personalized and Precision Medicine
News CMS aims for broader GLP-1 access via federal programmes CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
